article thumbnail

Respiri brings wheezo device and app to US market

pharmaphorum

Australian digital health company Respiri has rolled out its wheezo device, app and healthcare monitoring portal at Michigan Children’s Hospital, the first US customer for the technology. Access is now working on integration work with Michigan’s electronic medical record (EMR) system.

article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. In its announcement, the FDA advised individuals to keep their electronic or printed health records from the past year ready while seeking treatment.

Labelling 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rare disease: industry, patients and tech join forces on diagnosis

pharmaphorum

As an example, he highlights the company’s partnership with digital tool FindZebra and Danish university hospital Rigshospitalet. When the FDA Orphan Drug pathway was put in place in 2000, there were only eight rare disease treatments approved – now there are nearly 200 different treatments available. “R&D

article thumbnail

Philips makes another digital buy, as Thermo adds COVID-19 test maker

pharmaphorum

Between them, Royal Philips and Thermo Fisher have been driving a mini M&A spree in the medical technology sector, snapping up three companies in the last few weeks. Mesa has emergency use authorisation from the FDA for the COVID-19 application and full approvals for the other diseases.

article thumbnail

How pharmacists can help patients with New Year’s resolutions

The Checkup by Singlecare

Pharmacists can also review medication records to ensure that smoking cessation therapies do not interact with any of the client’s current medications. . The following agents, available by prescription, are FDA approved as adjuncts to diet and exercise for the long-term treatment of obesity: Adipex-P (oral phentermine).